All In Biotech

Drug Trial Radar · NCT07286175

A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)

A Phase 2, Multicenter, Randomized, Double-Blind, Parallel-Arm Study to Investigate the Efficacy and Safety of Adjunctive Treatment With Brenipatide in Delaying Time to Relapse Compared With Placebo in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 400 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

400

Planned (sponsor's estimate)

Start

Nov 24, 2025

Primary completion

Nov 2027

Study completion Nov 2027

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Dec 16, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the efficacy and safety of brenipatide when administered with standard of care (SoC), compared with placebo plus SoC in delaying the worsening of bipolar disorder symptoms. The trial is divided into three periods as follows: Screening period that will last approximately 1 month, treatment period that will last a minimum of 6 months, and the follow up period that will last approximately 2 months. The duration of study participation may vary and may be shortened if bipolar symptoms worsen or if withdrawal from the study occurs for any reason.

Conditions

  • Bipolar Disorder

Interventions

  • BrenipatideDrug

    Administered SC

  • PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to Relapse Defined as Days from Randomization to the Date on Which the Participant Meets Any Relapse CriterionTime frame: Randomization up to at least 6 months

Locations

87 sites in 8 countries. Site status is shown where the registry gives one.

  • ATP Clinical Research

    Orange, California · Recruiting

  • Yale University School of Medicine

    New Haven, Connecticut · Recruiting

  • AGA Clinical Trials

    Hialeah, Florida · Recruiting

  • Accel Research Sites - Maitland Clinical Research Unit

    Maitland, Florida · Recruiting

  • K2 Medical Research - Maitland

    Maitland, Florida · Recruiting

  • Floridian Clinical Research, LLC

    Miami Lakes, Florida · Recruiting

  • CLA Research

    Naples, Florida · Recruiting

  • Charter Research - Orlando

    Orlando, Florida · Recruiting

  • Encore Medical Research - Weston

    Weston, Florida · Recruiting

  • Atlanta Center for Medical Research

    Atlanta, Georgia · Recruiting

  • Covenant Medical Center

    Waterloo, Iowa · Recruiting

  • CBH Health

    Gaithersburg, Maryland · Recruiting

  • Elixia MA

    Springfield, Massachusetts · Recruiting

  • Adams Clinical Watertown

    Watertown, Massachusetts · Recruiting

  • Penn Medicine: University of Pennsylvania Health System

    Philadelphia, Pennsylvania · Recruiting

  • Revival Research Institute, LLC

    McKinney, Texas · Recruiting

  • Pillar Clinical Research - Richardson

    Richardson, Texas · Recruiting

  • Alpine Research Organization

    Clinton, Utah · Recruiting

  • Re:Cognition Health

    Fairfax, Virginia · Recruiting

  • Northwest Clinical Research Center

    Bellevue, Washington · Recruiting

  • Hospital Italiano de Buenos Aires

    ABB, Argentina · Not yet recruiting

  • Centro Neurobiológico y de Estrés Traumático (CENydET)

    Buenos Aires, Argentina · Recruiting

  • Instituto Nacional de Psicopatología (INAPsi)- FunDaMos

    Buenos Aires, Argentina · Recruiting

  • Stat Research S.A.

    Buenos Aires, Argentina · Recruiting

  • Mautalen Salud e Investigación

    Buenos Aires, Argentina · Recruiting

  • Instituto Médico DAMIC

    Córdoba, Argentina · Recruiting

  • Instituto Kremer

    Córdoba, Argentina · Recruiting

  • Centro Médico Luquez

    Córdoba, Argentina · Recruiting

  • Global Psy Asociación Civil

    La Plata, Argentina · Recruiting

  • Fundacion Scherbovsky

    Mendoza, Argentina · Recruiting

  • INECO Neurociencias Oroño

    Rosario, Argentina · Recruiting

  • Clinica El Jardin

    Santiago del Estero, Argentina · Recruiting

  • Chronos Pesquisa Clínica

    Brasília, Brazil · Recruiting

  • Instituto de Pesquisa clinica de Campinas

    Campinas, Brazil · Recruiting

  • Centro de Pesquisa Clínica de Marília - CPCLIM

    Marília, Brazil · Recruiting

  • Ruschel Medicina e Pesquisa Clínica

    Rio de Janeiro, Brazil · Recruiting

  • Facili Centro Integrado de Psiquiatria

    São Bernardo do Campo, Brazil · Recruiting

  • CPQuali Pesquisa Clínica

    São Paulo, Brazil · Recruiting

  • BR Trials - Ensaios Clinicos e Consultoria

    São Paulo, Brazil · Recruiting

  • Clinica Viver - Centro de Desospitalizacao Humana

    São Paulo, Brazil · Recruiting

Showing 40 of 87 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.